You must log in to view this page.

BridgeBio Pharma Inc. – Credit Agreements

NASDAQ: BBIO
Share price (9/30/26): $65.80
Market cap (9/30/26): $12.9 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Credit Agreements Filter

EX-10

from 10-K 100 pages Second Amendment to Loan and Security Agreement

12/34/56

EX-10.2

from 10-Q 92 pages First Amendment to Loan and Security Agreement

12/34/56

EX-10.39

from 10-K 93 pages Loan and Security Agreement

12/34/56

EX-10.3

from 10-Q 81 pages Sixth Amendment to Loan and Security Agreement

12/34/56

EX-10.46

from 10-K 97 pages Fifth Amendment to Loan and Security Agreement

12/34/56

EX-10.40

from 10-K 89 pages Third Amendment to Loan and Security Agreement

12/34/56

EX-10.1

from 10-Q 78 pages Fourth Amendment to Loan and Security Agreement

12/34/56

EX-10.1

from 8-K 38 pages Loan and Security Agreement

12/34/56

EX-10.18

from S-1 15 pages Second Amendment to Loan and Security Agreement

12/34/56

EX-10.7

from S-1 10 pages First Amendment to Loan and Security Agreement

12/34/56

EX-10.6

from S-1 46 pages Loan and Security Agreement

12/34/56

EX-10.7

from DRS/A 10 pages First Amendment to Loan and Security Agreement

12/34/56

EX-10.6

from DRS/A 46 pages Loan and Security Agreement

12/34/56

BridgeBio Pharma Inc. – Credit Agreements Watch

Search in Documents

Key Exhibits

External Links

Credit Agreements Filter

BridgeBio Pharma Inc. – Credit Agreements